Ketamine for treatment-resistant post-traumatic stress disorder: double-blind active-controlled randomised crossover study
BJPsych Open October 1, 2025 Ben Beaglehole, Paul Glue, Shona Neehoff et al. 5 citations
We provide preliminary support for the efficacy and tolerability of i.m. ketamine in a community sample of individuals with PTSD. Further work is required to establish the optimal dosing regimen and longer-term role of ketamine in treatment of PTSD, but our findings are encouraging given the well-known of treatments in this area.